The role of 5‐HT2B receptors in mitral valvulopathy: bone marrow mobilization of endothelial progenitors. (15th October 2017)
- Record Type:
- Journal Article
- Title:
- The role of 5‐HT2B receptors in mitral valvulopathy: bone marrow mobilization of endothelial progenitors. (15th October 2017)
- Main Title:
- The role of 5‐HT2B receptors in mitral valvulopathy: bone marrow mobilization of endothelial progenitors
- Authors:
- Ayme‐Dietrich, Estelle
Lawson, Roland
Côté, Francine
de Tapia, Claudia
Da Silva, Sylvia
Ebel, Claudine
Hechler, Béatrice
Gachet, Christian
Guyonnet, Jérome
Rouillard, Hélène
Stoltz, Jordane
Quentin, Emily
Banas, Sophie
Daubeuf, François
Frossard, Nelly
Gasser, Bernard
Mazzucotelli, Jean‐Philippe
Hermine, Olivier
Maroteaux, Luc
Monassier, Laurent - Abstract:
- Abstract : Background and Purpose: Valvular heart disease (VHD) is highly prevalent in industrialized countries. Chronic use of anorexigens, amphetamine or ergot derivatives targeting the 5‐HT system is associated with VHD. Here, we investigated the contribution of 5‐HT receptors in a model of valve degeneration induced by nordexfenfluramine, the main metabolite of the anorexigens, dexfenfluramine and benfluorex. Experimental Approach: Nordexfenfluramine was infused chronically (28 days) in mice ((WT and transgenic Htr 2B ‐/‐, Htr 2A ‐/‐, and Htr 2B/2A ‐/‐ ) to induce mitral valve lesions. Bone marrow transplantation was also carried out. Haemodynamics were measured with echocardiography; tissues and cells were analysed by histology, immunocytochemistry, flow cytometry and RT –qPCR. Samples of human prolapsed mitral valves were also analysed. Key Results: Chronic treatment of mice with nordexfenfluramine activated 5‐HT2B receptors and increased valve thickness and cell density in a thick extracellular matrix, mimicking early steps of mitral valve remodelling. Lesions were prevented by 5‐HT2A or 5‐HT2B receptor antagonists and in transgenic Htr 2B −/− or Htr 2A/2B −/− mice. Surprisingly, valve lesions were mainly formed by numerous non‐proliferative CD34 + endothelial progenitors. These progenitors originated from bone marrow (BM) as revealed by BM transplantation. The initial steps of mitral valve remodelling involved mobilization of BM‐derived CD34 + CD31 + cellsAbstract : Background and Purpose: Valvular heart disease (VHD) is highly prevalent in industrialized countries. Chronic use of anorexigens, amphetamine or ergot derivatives targeting the 5‐HT system is associated with VHD. Here, we investigated the contribution of 5‐HT receptors in a model of valve degeneration induced by nordexfenfluramine, the main metabolite of the anorexigens, dexfenfluramine and benfluorex. Experimental Approach: Nordexfenfluramine was infused chronically (28 days) in mice ((WT and transgenic Htr 2B ‐/‐, Htr 2A ‐/‐, and Htr 2B/2A ‐/‐ ) to induce mitral valve lesions. Bone marrow transplantation was also carried out. Haemodynamics were measured with echocardiography; tissues and cells were analysed by histology, immunocytochemistry, flow cytometry and RT –qPCR. Samples of human prolapsed mitral valves were also analysed. Key Results: Chronic treatment of mice with nordexfenfluramine activated 5‐HT2B receptors and increased valve thickness and cell density in a thick extracellular matrix, mimicking early steps of mitral valve remodelling. Lesions were prevented by 5‐HT2A or 5‐HT2B receptor antagonists and in transgenic Htr 2B −/− or Htr 2A/2B −/− mice. Surprisingly, valve lesions were mainly formed by numerous non‐proliferative CD34 + endothelial progenitors. These progenitors originated from bone marrow (BM) as revealed by BM transplantation. The initial steps of mitral valve remodelling involved mobilization of BM‐derived CD34 + CD31 + cells by 5‐HT2B receptor stimulation. Analysis of human prolapsed mitral valves showing spontaneous degenerative lesions, demonstrated the presence of non‐proliferating CD34 + /CD309 + /NOS3 + endothelial progenitors expressing 5‐HT2B receptors. Conclusions and Implications: BM‐derived endothelial progenitor cells make a crucial contribution to the remodelling of mitral valve tissue. Our data describe a new and important mechanism underlying human VHD. … (more)
- Is Part Of:
- British journal of pharmacology. Volume 174:Number 22(2017)
- Journal:
- British journal of pharmacology
- Issue:
- Volume 174:Number 22(2017)
- Issue Display:
- Volume 174, Issue 22 (2017)
- Year:
- 2017
- Volume:
- 174
- Issue:
- 22
- Issue Sort Value:
- 2017-0174-0022-0000
- Page Start:
- 4123
- Page End:
- 4139
- Publication Date:
- 2017-10-15
- Subjects:
- Pharmacology -- Periodicals
Chemotherapy -- Periodicals
Drug Therapy -- Periodicals
Pharmacology -- Periodicals
615.1 - Journal URLs:
- http://bibpurl.oclc.org/web/21844 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1476-5381/issues ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=282&action=archive ↗
http://onlinelibrary.wiley.com/ ↗
http://www.nature.com/bjp/index.html ↗ - DOI:
- 10.1111/bph.13981 ↗
- Languages:
- English
- ISSNs:
- 0007-1188
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2314.700000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 8549.xml